comparemela.com

Latest Breaking News On - அமர் ஜேசனி - Page 7 : comparemela.com

Indian opposition takes jab at Modi over vaccine shortage, COVID-19 crisis

Indian opposition takes jab at Modi over vaccine shortage, COVID-19 crisis
arabnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabnews.com Daily Mail and Mail on Sunday newspapers.

Probe sought into deaths and adverse effects after COVID-19 vaccinations

Updated: March 17, 2021 15:05 IST A group of experts have written a letter to Health Minister Harsh Vardhan and Drugs Controller General of India V.G. Somani. Share Article AAA A group of experts have written a letter to Health Minister Harsh Vardhan and Drugs Controller General of India V.G. Somani. A group of experts in public health, ethics, medicine, law, and journalism have written to Health Minister Harsh Vardhan and Drugs Controller General of India V.G. Somani, appealing for “time-bound and transparent investigation” following deaths and serious adverse effects after COVID-19 vaccination. “We understand that at least 65 deaths have occurred following vaccination for COVID-19 since the vaccination campaign started on January 16. However, the National AEFI (adverse event following immunisation) Committee’s investigation findings of only two of these deaths have been made public. We believe that due to the possible linkages of vaccination and blood clotting, all

Covid-19 vaccines: Investigate adverse events and make reports public, say public health professionals

Covid-19 vaccines: Investigate adverse events and make reports public, say public health professionals March 17, 2021 EMA report on AstraZeneca-Oxford vaccine and blood clot reports expected tomorrow Even as the European Medicines Agency (EMA) reviews the AstraZeneca-Oxford University vaccine after more than 10 countries temporarily suspended its use, a group of public health professionals have called for an investigation of deaths and serious adverse events in India as well. “AEFIs (adverse events following immunisation) are to be investigated through well-defined procedures for vaccine pharmacovigilance, and the reports made available in the public domain, for trust-building and transparency,” the public health representatives said in a letter to Health Minister Dr Harsh Vardhan and others involved with the vaccines programme.

29 experts write to Centre seeking urgent probe into deaths, AEFIs after COVID vaccination

29 experts write to Centre seeking urgent probe into deaths, AEFIs after COVID vaccination
newindianexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newindianexpress.com Daily Mail and Mail on Sunday newspapers.

Covaxin or Covishield? What you should know about each COVID-19 vaccine

Covaxin or Covishield? What you should know about each COVID-19 vaccine © Viswanath Pilla Covaxin or Covishield? What you should know about each COVID-19 vaccine Beginning March, India has extended COVID-19 vaccination to include people above 60 years, and those who are 45-plus with co-morbidities. So far 24.3 million people in the country have got at least one dose of COVID-19 vaccine. There isn t much choice for people in India between Serum Institute of India’s (SII) Covishield and Bharat Biotech s Covaxin. Covishield, which has been widely used for inoculation, is manufactured and distributed by SII with a license from AstraZeneca-Oxford University. Here is a guide to help you understand the important facts about each of these vaccines.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.